BlackRock’s Novelion Therapeutics Inc. Common Shares NVLN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-3,289	Closed	-$2K	–	5137
2019 Q2	$2K	Sell	3,289 -37,825	-92%	-$42.1K	﹤0.01%	4933
2019 Q1	$51K	Sell	41,114 -2,814	-6%	-$3.2K	﹤0.01%	4476
2018 Q4	$37K	Sell	43,928 -804	-2%	-$908	﹤0.01%	4515
2018 Q3	$132K	Buy	44,732 +1,809	+4%	+$6.4K	﹤0.01%	4405
2018 Q2	$158K	Sell	42,923 -637,682	-94%	-$2.56M	﹤0.01%	4370
2018 Q1	$2.38M	Sell	680,605 -10,259	-1%	-$43.5K	﹤0.01%	3637
2017 Q4	$2.15M	Buy	690,864 +11,375	+2%	+$54.7K	﹤0.01%	3672
2017 Q3	$4.78M	Buy	679,489 +13,028	+2%	+$104K	﹤0.01%	3476
2017 Q2	$6.15M	Buy	666,461 +654,842	+5,636%	+$6.31M	﹤0.01%	3403
2017 Q1	$125K	Buy	11,619 +6,117	+111%	+$62.5K	﹤0.01%	4297
2016 Q4	$46K	Buy	+5,502	New	+$48.7K	﹤0.01%	2980